Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Clinical trial NCT02465450 · COMPLETED
Trial details
- NCT number
- NCT02465450
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-29
- Primary completion
- 2016-12-28
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.